Lv2
180 积分 2025-11-23 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
29天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
[Analysis of the clinical characteristics of 8 081 primary lung cancer]
6个月前
已完结
皖公网安备34019202002308
